Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Official Title: Gastroprotected Superoxide Dismutase in Combination With UVB vs Placebo and UVB for Treating Vitiligo. A Randomized Double Blind Placebo Controlled Monocentric Study
In Brief: Glisodin 4 pills a day (1000mg) for 3 months then 2 pills a day (500 mg) for 3 months
Ages Eligible: 18 Years and older
Start Date: June 17, 2019
Completion Date (estimated): November 2, 2020
Status: Active, recruiting
Study ID from ClinicalTrials.gov: NCT03941808
Location: Centre Hospitalier Universitaire de Nice at Nice, Alpes-Maritime, France, 06001
Contact: To learn more about this study, you or your doctor may contact Passeron Thierry, PhD by phone +33492034688 or email passeron.t@chu-nice.fr. Please refer to this study by its NCT number.
FAQOther Questions
- Does halo nevi affect vitiligo development?
Halo nevi — nevi with an depigmented circle around it, usually on the trunk — are about 10x more common in vitiligo patients than in the general population, especially in childr...
- How to get insurance coverage for vitiligo treatments?
Most of health insurance companies will initially reject claims for vitiligo doctor visits or phototherapy treatments but with enough efforts you can have a substantial part of ...
- Is there a traditional medicine to treat vitiligo?
Traditional medicines may be helpful in chronic, metabolic, and stress-related conditions early in the disease manifestation, before extensive tissue and organ damage has occurr...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.